JPRN-C000000049
Completed
未知
A phase I/II study of transarterial chemoembolization with cisplatin for hepatocellular carcinoma (JIVROSG-0401) - Transarterial chemoembolization with cisplatin for hepatocellular carcinoma(JIVROSG-0401)
Japan Interventional Radiology in Oncology Study Group (JIVROSG)0 sites60 target enrollmentAugust 7, 2005
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- nresectable hypervascular hepatocellular carcinoma
- Sponsor
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Prior chemotherapy with cisplatin for HCC. 2\) Suspicious of extra\-hepatic arterial blood supply to lesions on contrast\-enhanced CT. 3\) Extra\-hepatic arterial blood supply to lesions on prior angiography. 4\) Surgical reconstruction or endoscopic treatment involving biliary system. 5\) Lymphnode metastasis or distant metastasis. 6\) Other uncontrolled severe illness. 7\) Active infectious disease except viral hepatitis. 8\) Active other malignancies. 9\) Allergic reaction to iodine contrast material, platinum containing agent, or gelatin containing agent. 10\) Pregnant or nursing.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
Phase I study of transarterial chemoembolization using Cisplatin powder and miriplatin in patients with hepatocellular carcinomaJPRN-UMIN000010431Southern TOHOKU General Hospital10
Active, not recruiting
Not Applicable
Phase II study evaluating transarterial chemoembolization (TACE) in combination with sorafenib for the treatment of advanced hepatocellular carcinoma (HCC) - TACE and sorafenib for HCChistologically proven advanced hepatocellular carcinoma (HCC) not suitable for resection or liver transplantation but without extrahepatic manifestations and without previous treatment for HCCMedDRA version: 9.1Level: LLTClassification code 10019828Term: Hepatocellular carcinoma non-resectableEUCTR2007-000730-40-DEHeinrich-Heine-Universität Düsseldorf
Completed
Phase 2
Phase II trial of Transarterial Chemoembolization using Drug-eluting bead for advanced HCC refractory to Lipiodol-TACEadvanced hepatocellular carcinomaJPRN-UMIN000015463Clinical Research Group of the Japanese Society for Transcatheter Hepatic Arterial Embolization24
Completed
Phase 1
Phase I/II study of transcatheter arterial chemo-embolization with DDP-H and degradable starch microspheres for hepatic metastases of colorectal cancerColorectal CancerJPRN-UMIN000001168Radiology, Nara Medical University Hospital27
Completed
Phase 2
PhaseII study of trancatheter arterial chemoembolizaion with miriplatin for hepatocellular carcinoma -Compared with retrospective historical cohort study with epirubicin hydrochlorideJPRN-UMIN000005229ara Medical University, Department of Radiology33